1546 records found.
Nov 14, 2019
Integral Molecular to Advance Vaccine Discovery with NIH Contract for $5.5M
Nov 14, 2019
I-Mab Biopharma Receives IND Approval from NMPA to Initiate Clinical Trials for its Anti-GM-CSF Monoclonal Antibody TJM2 in China
Nov 12, 2019
Agenus to Host R&D Day November 15, 2019
Nov 11, 2019
Akesobio Presents Phase 1 Clinical Data from First-in-class Bispecific Drug Candidate AK104 (PD1/CTLA4) As Oral Presentation, at 2019 SITC Annual Meeting
Nov 11, 2019
Kymera Therapeutics to Present Preclinical Data on its First-in-Class IRAK4 Degraders Demonstrating Robust Inhibition of Inflammatory Responses and Superiority to IRAK4 Kinase Inhibitors
Nov 11, 2019
Agenus receives $10M from UroGen Pharma for rights to Zalifrelimab (CTLA-4) for intravesical treatment of urinary tract cancers
Nov 11, 2019
Lupus Research Alliance Response to Positive Data from Phase 3 Anifrolumab Trial Presented at 2019 ACR/ARP Annual Meeting
Nov 10, 2019
Nektar Therapeutics Presents Data from First-in-Human Phase 1a Study on Novel T Regulatory Cell Stimulator, NKTR-358 at 2019 Annual Meeting of the American College of Rheumatology
Nov 09, 2019
Nektar Therapeutics Presents New Clinical and Preclinical Data from its Immuno-Oncology Pipeline at the 2019 Society for Immunotherapy of Cancer (SITC) Annual Meeting
Nov 08, 2019
Latest Developments in the Interleukin-2 (IL-2) Research and Development, 2019 Report
Nov 07, 2019
IgG4-Related Disease Epidemiology Forecast Report 2019-2028
Nov 07, 2019
Survey Shows People Who First Developed Atopic Dermatitis Symptoms As Kids Experience More Severe Symptoms
Nov 06, 2019
Alligator Bioscience: ATOR-1017 Induces Long-Lasting Immunity - New Preclinical Data to be Presented at SITC 34th Annual Meeting
Nov 06, 2019
Compugen Expands Patent Portfolio for COM902 with New Composition of Matter and Use Patent in Europe
Nov 06, 2019
Regeneron to Report Results from CD20xCD3 and BCMAxCD3 Bispecifics and C5 Antibody Programs at ASH Annual meeting
Nov 06, 2019
Kleo Pharmaceuticals Presents Preclinical Data Supporting Development of its CD38-ARM(TM), a Novel Immuno-therapeutic, at American Society of Hematology (ASH) Annual Meeting
Nov 05, 2019
Bolt Biotherapeutics Announces ISAC Data Presentation At the Annual Meeting of the Society for Immunotherapy of Cancer (SITC)
Nov 05, 2019
Compugen Presents Preclinical Data for COM902 Anti-TIGIT Program at SITC 2019
Nov 05, 2019
Global Protein Engineering Market (2019 - 2024)
Nov 05, 2019
A2 Biotherapeutics Emerges From Stealth Mode With $57M Series A To Develop A Pipeline Of Selective Tumor Cell Therapeutics

Pages